| POSTGRADUATE COURSE PROGRAMME: |
“Clinical Research Update and Transcatheter Valve Therapy” Course Directors: David Adams, Jeffrey Borer, Michael Borger, Johanna Takkenberg |
| Saturday, June 25 |
| 07:00 - 08:00 |
|
Registration |
I. Valvular Therapy Potpourri (08:00 – 09:30) Moderators: Maurice Sarano (Rochester), David Adams (New York) |
| 08:00 - 08:20 |
|
Epidemiology, classification, and clinical relevance of bicuspid aortic valve disease – Efstratios I. Charitos (Luebeck) |
| 08:20 - 08:40 |
|
Surgical considerations for the bicuspid aortic valve – John Ikonomidis (Charleston) |
| 08:40 - 09:00 |
|
Severe mitral regurgitation: When should patients be referred for surgery? When should they be observed? – Maurice Sarano (Rochester) |
| 09:00 - 09:20 |
|
Barlow’s disease and fibroelastic deficiency: Why is it important to differentiate? – David Adams (New York) |
| 09:20 - 09:30 |
|
Discussion |
| 09:30 - 10:00 |
|
Coffee Break |
II. Clinical Research Update (10:00 – 12:30) Moderators: Michael Borger (Leipzig), Johanna Takkenberg (Rotterdam) |
| 10:00 - 10:20 |
|
PARTNER Trial Arms A and B: Good news for everyone? – Thomas Walther (Bad Nauheim) |
| 10:20 - 10:40 |
|
EVEREST II Trial: Where do we go from here? – Holger Thiele (Leipzig) |
| 10:40 - 11:00 |
|
Randomized trials in valvular heart therapy: Are they feasible? – Jeffrey Borer (New York) |
| 11:00 - 11:20 |
|
Statin therapy for aortic valvular disease: Is there still a role? – Johanna Takkenberg (Rotterdam) |
| 11:20 - 11:40 |
|
Minimal invasive versus conventional mitral valve surgery: ISMICS position paper – Ehud Raanani (Tel HaShomer) |
| 11:40 - 12:00 |
|
Dabigatran for prevention of thromboembolism in atrial fibrillation: Implications for mechanical valve therapy? – Mostafa Mokhles (Rotterdam) |
| 12:00 - 12:20 |
|
STICH trial: Results, insights and implications (including for the mitral valve) – Robert Bonow (Chicago) |
| 12:20 - 12:30 |
|
Discussion |
| 12:30 - 13:30 |
|
Lunch Break |
III. Transcatheter Therapy (13:30 – 15:30) Moderators: Blase Carabello (Houston), Ruediger Lange (Munich) |
| 13:30 - 13:50 |
|
Starting a successful transapical program – Ruediger Lange (Munich) |
| 13:50 - 14:10 |
|
TAVI therapy: A cardiologist’s perspective - Blase Carabello (Houston) |
| 14:10 - 14:30 |
|
Elective and emergent valve-in-valve therapy: Indications and results – Joerg Kempfert (Bad Nauheim) |
| 14:30 - 14:50 |
|
Echocardiography during TAVI: Is it necessary? - Joerg Ender (Leipzig) |
| 14:50 - 15:10 |
|
Transapical MV repair / replacement: What does the future hold? – Francesco Maisano (Milan) |
| 15:10 - 15:30 |
|
Discussion |
| 15:30 - 16:00 |
|
Coffee Break |
IV. The Future (16:00 – 17:15)
|
| 16:00 - 16:20 |
|
Mitral valve rings: Which device for which patients? – Robert Klautz (Leiden) |
| 16:20 - 16:40 |
|
Functional heart valve tissue engineering – Carlijn Bouten (Eindhoven) |
| 16:40 - 17:10 |
|
Special Lecture “What the future cardiac surgeon needs to know and do” - Fred Mohr (Leipzig)
|
| 17:10 - 17:15 |
|
Closing Remarks - Jeffrey Borer (New York) |
| 17:30 |
|
Biennial Meeting Welcome Reception Blue Salon, Hotel Rey Juan Carlos |